COVID-19 AND NEUROMUSCULAR DISEASE
In order to inform the neurological community and patients, the Italian Association of the Peripheral Nervous System (ASNP), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Society of Neurology (SIN) have developed a joint document to guide best practice for managing patients with immune-mediated neuropathy during the global spread of COVID-19. The document is a collection of advice developed by neurologists with expertise in immune-mediated polyneuropathies including chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, Lewis-Sumner syndrome, polyneuropathies associated with monoclonal gammopathy with or without anti-MAG antibodies and neuropathies associated with vasculitis. The authors underline that these practical recommendations should be individualised according to the severity and progression of the neuropathy, local healthcare strategic planning and COVID-19 infection risk.
by Marialuisa Zedde and Francesco Cavallieri